Miller Value Partners is Betting on Teva Pharmaceutical Industries (TEVA) StockInsider Monkey • 11/02/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Teva Pharmaceuticals Industries Limited of Class Action Lawsuit and Upcoming Deadline - TEVAPRNewsWire • 11/01/20
ROSEN, A LEADING LAW FIRM, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVAPRNewsWire • 10/31/20
Rosen, Top Ranked Investor Counsel, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVANewsfile Corp • 10/28/20
Rosen, A Trusted and Leading Law Firm, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVANewsfile Corp • 10/17/20
Teva New Case Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The FirmNewsfile Corp • 10/16/20
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVAPRNewsWire • 10/15/20
Rosen, A Longstanding and Trusted Firm, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVANewsfile Corp • 10/09/20
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfrm) Injection Published in HeadacheBusiness Wire • 10/07/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Teva Pharmaceuticals Industries Limited Investors of the Important November 23 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – TEVABusiness Wire • 10/05/20
Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial AsthmaBusiness Wire • 10/05/20
U.S. federal appeals court reinstates GSK’s £182 million ruling against Teva PharmaceuticalInvezz • 10/04/20
Rosen, A Top Ranked Law Firm, Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors with Losses in Excess of $500K to Contact the Firm - TEVANewsfile Corp • 10/02/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of InvestorsBusiness Wire • 10/01/20
Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020Business Wire • 10/01/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Teva Pharmaceutical Industrial Limited (TEVA) on Behalf of InvestorsBusiness Wire • 10/01/20
Teva Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Teva Pharmaceutical Industries Limited To Contact The FirmNewsfile Corp • 09/28/20
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 09/28/20
ROSEN, LEADING INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Teva Pharmaceuticals Industries Limited; Encourages Investors with Losses in Excess of $100K to Contact the Firm - TEVAPRNewsWire • 09/25/20
